0000000000774423

AUTHOR

Giorgia Monterossi

showing 2 related works from this author

How Technology Can Impact Surgeon Performance: A Randomized Trial Comparing 3-Dimensional versus 2-Dimensional Laparoscopy in Gynecology Oncology

2016

This randomized clinical trial (Canadian Task Force classification I) aimed to compare 2-dimension (2-D) versus 3-dimensional (3-D) laparoscopic hysterectomy and pelvic lymphadenectomy in endometrial and cervical cancer patients. Between December 2014 and March 2015, 90 patients were enrolled: 29 (32.2%) with early or locally advanced cervical cancer after neoadjuvant treatment and 61 (67.8%) with early-stage endometrial cancer. Patients were randomly assigned to undergo 2-D (Group A, n = 48 [53.3%]) or 3-D (Group B, n = 42 [46.7%)]) laparoscopy. Baseline characteristics were superimposable in the 2 groups. Median operative time was similar in the 2 groups. Median estimated blood loss durin…

Adultmedicine.medical_specialtymedicine.medical_treatmentOperative TimeUterine Cervical NeoplasmsHysterectomylaw.invention03 medical and health sciencesImaging Three-DimensionalPostoperative Complications0302 clinical medicineRandomized controlled trialEndometrial cancerlawThree-dimensional laparoscopicmedicineHumansLaparoscopyNeoadjuvant therapyCervical cancer; Endometrial cancer; Three-dimensional laparoscopicAgedSurgeonsGynecologyCervical cancerHysterectomymedicine.diagnostic_testbusiness.industryEndometrial cancerGeneral surgeryObstetrics and GynecologyPerioperativeMiddle Agedmedicine.diseaseNeoadjuvant TherapyEndometrial NeoplasmsSurgery030220 oncology & carcinogenesisCervical cancerLymph Node ExcisionFemaleLaparoscopy030211 gastroenterology & hepatologyLymphadenectomyClinical CompetenceCervical cancer; Endometrial cancer; Three-dimensional laparoscopic; Obstetrics and Gynecologybusiness
researchProduct

Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.

2018

ObjectiveThe identification of patients with endometrial cancer (EC) at higher risk for relapse is critical to individualize and better tailor postoperative treatment. No evidence is available regarding the possible association between tumor size (TS) and the risk of local recurrence. The purpose of this study was to analyze the correlation between TS and risk/type of recurrence in EC patients, stratified according to the new European Society of Medical Oncology-European Society of Gynecological Oncology-European Society for Radiotherapy and Oncology classification.MethodsData of patients with histologically proven EC who received primary surgical treatment between November 1999 and June 20…

Oncologymedicine.medical_specialtyPrognostic factormedicine.medical_treatmentRome03 medical and health sciencesEndometrium0302 clinical medicineEndometrial cancerRetrospective StudieRisk FactorsInternal medicinemedicineLocal recurrenceHumansEndometrial NeoplasmRisk factorAgedRetrospective Studies030219 obstetrics & reproductive medicineReceiver operating characteristicTumor sizebusiness.industryRisk FactorEndometrial cancerDistant relapseLocal relapseObstetrics and GynecologyRetrospective cohort studyTumor sizeMiddle Agedmedicine.diseaseEndometrial NeoplasmsRadiation therapyEndometrial cancer; Local recurrence; Local relapse; Tumor size; Vaginal relapse; Oncology; Obstetrics and GynecologyNeoplasm RecurrenceSettore MED/40 - GINECOLOGIA E OSTETRICIALocalReproductive MedicineOncology030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalbusinessVaginal relapseHumanInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct